ERVEBO is an Ebola Zaire vaccine
Tradename: ERVEBO Proper Name: Ebola Zaire Vaccine, Live Indication: To extend the indication for use to include individuals 12 months of age and older. ERVEBO is a vaccine indicated for…
Tradename: ERVEBO Proper Name: Ebola Zaire Vaccine, Live Indication: To extend the indication for use to include individuals 12 months of age and older. ERVEBO is a vaccine indicated for…
Name: Xdemvy Indications: To treat Demodex blepharitis. Active Ingredient: Lotilaner Company: Tarsus Pharmaceuticals, Inc. Approval Date: 7/25/2023 More Details: https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217603s000lbl.pdf
Tradename: BALFAXAR Proper Name: prothrombin complex concentrate, human-lans Indication: Indicated for the urgent reversal of acquired coagulation factor deficiency induced by Vitamin K antagonist (VKA, e.g., warfarin) therapy in adult…
Name: Vanflyta Indications: To use as part of a treatment regimen for newly diagnosed acute myeloid leukemia that meets certain criteria. Active Ingredient: Quizartinib Company: Daiichi Sankyo, Inc Approval Date:…
Tradename: CYFENDUS Proper Name: Anthrax Vaccine Adsorbed, Adjuvanted Indication: Indicated for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis in persons 18 through 65 years of…
Tradename: DENGVAXIA Proper Name: Dengue Tetravalent Vaccine, Live Indication: To include safety and efficacy data that support the use of DENGVAXIA in individuals 6 through 16 years of age with…
Tradename: ROCTAVIAN Proper Name: valoctocogene roxaparvovec-rvox Indication: Valoctocogene roxaparvovec-rvox is an adeno-associated virus vector-based gene therapy indicated for the treatment of adults with severe hemophilia A (congenital factor VIII deficiency…
Drug Name: Ngenla Indications: To treat growth failure due to inadequate secretion of endogenous growth hormone. Active Ingredient: Somatrogon-ghla Company: Pfizer Inc, OPKO Health Inc Approval Date: 6/27/2023 More…
Tradename: LANTIDRA Proper Name: donislecel-jujn Indication: Indicated for the treatment of adults with Type 1 diabetes who are unable to approach target HbA1c because of current repeated episodes of severe…
Drug Name: Rystiggo Indications: To treat generalized myasthenia gravis in adults who are anti-acetylcholine receptor- or anti-muscle-specific tyrosine kinase antibody-positive. Active Ingredient: Rozanolixizumab-noli Company: UCB, Inc Approval Date: 6/26/2023 More…